Ferring Pharmaceuticals And Karolinska Institute Sign Collaboration Agreement On The Development Of A Human Microbiome Translational Research Programme
SAINT-PREX, Switzerland--(BUSINESS WIRE)--Ferring Pharmaceuticals and Karolinska Institutet announce today that a collaboration agreement has been signed for the establishment of a research center exploiting the human microbiome. The programme will be fully funded by Ferring Pharmaceuticals and governed by a joint steering committee.